In a statement following their filed amicus brief, the Partnership for Protecting Coverage called on the U.S. Court of Appeals for the Fifth Circuit to preserve access to evidence-based preventative services without cost-sharing as required under the Affordable Care Act as the court hears oral arguments in Braidwood v. Becerra.
Site Search
In a letter to the Tennessee Senate Committee on Commerce and Labor, the Cystic Fibrosis Foundation expressed support for SB 2008 which would require covered benefits to be considered essential health benefits and limit alternative funding programs in state-regulated plans.
In a letter to bill sponsors, the Cystic Fibrosis Foundation signaled their endorsement of H.R. 5434, the Stabilize Medicaid and CHIP Coverage Act, which will provide reliable access to care and continuous coverage to all adult Medicaid beneficiaries.
In a letter to bill sponsors, the Cystic Fibrosis Foundation expressed their support of S.3138, the Stabilize Medicaid and CHIP Coverage Act, which will provide reliable access to care and continuous coverage to all adult Medicaid beneficiaries.
The Cystic Fibrosis Foundation joined the Partnership for Protecting Coverage in a letter to Alabama legislators opposing SB 232, a bill that could ultimately authorizing a nonprofit agriculture organization to offer health benefits to its members.
In a letter to the Rhode Island General Assembly, the Cystic Fibrosis Foundation expressed its support of 8041, which if passed, would ban all state-regulated payers from including co-pay accumulator programs in their health insurance plans.
In a letter to Colorado legislators, the Cystic Fibrosis Foundation expressed its support for SB 24-203 which, if passed, would require that the state’s Prescription Drug Affordability Board consider orphan drug status and, if the drug is an orphan drug, patient input when selecting drugs for affordability review.
The Cystic Fibrosis Foundation joined the Partnership for Protecting Coverage in a letter to the U.S. Department of Health and Human Services supporting CHIP eligibility expansion in Florida but opposing a proposal that would disenroll families who fail to pay premiums.
In a letter to Mississippi legislators, the Cystic Fibrosis Foundation expressed support for HB 1725 which, if passed, would expand eligibility for Medicaid. The letter also urged legislators to ensure that the bill expands eligibility to adults with incomes up to 138% of the federal poverty line.
In a letter to the Vermont Senate, the Cystic Fibrosis Foundation expressed its support for HB 233, which, if passed, would ban co-pay accumulator programs in the state and require covered benefits to be considered essential health benefits.